Abstract:BACKGROUND: Proper inflammation resolution is critical for cutaneous wound healing and disordered inflammation resolution results in chronic nonhealing wounds. However, the cellular and molecular mechanisms for resolution of inflammation during skin wound healing are not well understood. MicroRNA-34a is regarded as one tumor suppressor with complexed immune regulatory effects, yet its role during skin wound repair is still unclear.METHODS: Circular full thickness excisional wounds were made on the dorsal skin of C57 mice and miR-34a expression pattern was examined by real time RT-PCR and in situ hybridization. The wound healing rates and histologic morphometric analysis were quantified and compared between wounds treated with antagomir-34a and autologous control antagomir-NC wounds, as well as wounds between miR-34a knockout (KO) and wild type (WT) mice. Immunohistochemistry (IHC) for both MPO and F4/80 were performed to examine the infiltrative neutrophils and macrophages in wounds from miR-34a KO and WT mice. Cytokines including IL-1β, IL-6, TNF-α and IL-10, were detected and analyzed by real time RT-PCR during wound healing. IHC for IL-6 and p-STAT3 were quantified, and WB for p-STAT3 and IL-6R were examined in wounds of miR-34a KO and WT mice.RESULTS: We found miR-34a was significantly downregulated in the inflammatory phase and back to normal levels in the proliferative phase. Both topical knockdown wounds miR-34a levels by antagomir gel and systematic knockout miR-34a using KO mice resulted in impaired wound healing with delayed re-epithelialization and augmented inflammation. IHC results indicated that there were more residual infiltrative inflammatory cells in the proliferative phase. Moreover, over-activated IL-6/STAT3 signal pathway was identified in the wounds of miR-34a KO mice.CONCLUSIONS: Our findings reveal that miR-34a deficiency augments skin wound inflammation response and leads to impaired wound healing, which suggest that targeted inhibition of miR-34a for tissue repair/regeneration should be with serious consideration.

Cutaneous Wounds in Mice Lacking TSG-6 Exhibit Delayed Closure and an Abnormal Inflammatory Response

Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates a Role for TSG-6 to Retain Hyaluronan Inside Epidermis

Enhanced Angiogenesis and Reduced Contraction in Thrombospondin-2–null Wounds is Associated with Increased Levels of Matrix Metalloproteinases-2 and −9, and Soluble VEGF

Jagged-1+ Skin Tregs Modulate the Innate Immune Response to Wound Healing

Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis

TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8

Anti-inflammatory protein tumor necrosis factor-α-stimulated protein 6 (TSG-6) promotes early gingival wound healing: an in vivo study

Role Of Tgf Beta-Mediated Inflammation In Cutaneous Wound Healing

Jagged-1+ skin Tregs modulate cutaneous wound healing

Eif6 Modulates Skin Wound Healing by Upregulating Keratin 6B.

IL-36 receptor antagonist deficiency resulted in delayed wound healing due to excessive recruitment of immune cells

Tumor Necrosis Factor‐alpha (tnf‐α) is a Therapeutic Target for Impaired Cutaneous Wound Healing

Wound-healing defect of CD18−/− mice due to a decrease in TGF-β1 and myofibroblast differentiation

TSG-6: a pluripotent inflammatory mediator?

TAK1 is Required for Dermal Wound Healing and Homeostasis.

MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice

Transforming Growth Factor- ReceptoreMediated, p38 Mitogen-Activated Protein KinaseeDependent Signaling Drives Enhanced Myofibroblast Differentiation during Skin Wound Healing in Mice Lacking Hyaluronan Synthases 1 and 3

Transforming Growth Factor-β Receptor-Mediated, p38 Mitogen-Activated Protein Kinase-Dependent Signaling Drives Enhanced Myofibroblast Differentiation during Skin Wound Healing in Mice Lacking Hyaluronan Synthases 1 and 3.

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin

TSG6 as a central mediator of macrophage M2 polarization (IRC5P.626)